| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1998PNAS...95.3851Z |
| P356 | DOI | 10.1073/PNAS.95.7.3851 |
| P932 | PMC publication ID | 19926 |
| P698 | PubMed publication ID | 9520456 |
| P5875 | ResearchGate publication ID | 51314512 |
| P50 | author | Robert Gallo | Q469904 |
| P2093 | author name string | A Lachgar | |
| B Bizzini | |||
| D Zagury | |||
| J Bernard | |||
| M Feldman | |||
| A Gringeri | |||
| A Burny | |||
| E Santagostino | |||
| J Rappaport | |||
| J F Zagury | |||
| L S Fall | |||
| V Chams | |||
| P2860 | cites work | HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 |
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA | Q24558732 | ||
| Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120 | Q28237119 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding | Q28252493 | ||
| Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 | ||
| Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus | Q28302762 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| Efficacy of chloramphenicol in the treatment of neonatal and infantile meningitis: a study of 70 cases | Q33475749 | ||
| HTLV-III in Cells Cultured from Semen of Two Patients with AIDS | Q34250519 | ||
| Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis | Q34536238 | ||
| Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging | Q34581195 | ||
| Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | Q34593057 | ||
| Convenient assay for interferons | Q35235975 | ||
| Interferons in the persistence, pathogenesis, and treatment of HIV infection | Q35311104 | ||
| Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis | Q36478616 | ||
| Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy | Q40756417 | ||
| Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. | Q41335848 | ||
| Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein | Q41349382 | ||
| Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma | Q41435232 | ||
| Anergic T cells as suppressor cells in vitro | Q41461549 | ||
| Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients | Q41734588 | ||
| Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. | Q43692324 | ||
| Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta | Q43783366 | ||
| The induction of interferons and related problems. | Q44933730 | ||
| Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals | Q45347989 | ||
| Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report | Q45878245 | ||
| Induction of bystander T cell proliferation by viruses and type I interferon in vivo | Q46486509 | ||
| Association of phenotypic reversion of transformed cells induced by interferon with morphological and biochemical changes in the cytoskeleton | Q53569889 | ||
| T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover | Q57204184 | ||
| Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro | Q57997807 | ||
| Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway | Q63351477 | ||
| Repairing the T-cell defect in AIDS | Q69868799 | ||
| The neglected role of type I interferon in the T-cell response: implications for its clinical use | Q71475326 | ||
| CD4+ and CD8+ Lymphocytes of Patients with AIDS Synthesize Increased Amounts of Interferon-γ | Q71798940 | ||
| CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection | Q72674545 | ||
| Involvement of alpha-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment | Q72698355 | ||
| A naturally unbalanced combat [new; comment] | Q73034270 | ||
| Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunosuppression | Q1455316 |
| P304 | page(s) | 3851-3856 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. | |
| P478 | volume | 95 |
| Q34098868 | A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice |
| Q43618512 | A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid |
| Q35090142 | Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases |
| Q24517026 | Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteins |
| Q35687684 | Anti-cytokine Ab immune therapy: present status and perspectives |
| Q44225152 | Anticytokine therapy--new approach to the treatment of autoimmune and cytokine-disturbance diseases |
| Q35847699 | CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis |
| Q36483328 | Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics |
| Q37348901 | Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization |
| Q37347813 | Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. |
| Q59511395 | Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine |
| Q35914471 | Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha. |
| Q24802232 | Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot study |
| Q34557110 | Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. |
| Q35785054 | Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T c |
| Q78402091 | Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients |
| Q37010956 | Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen |
| Q38457134 | HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand |
| Q36141492 | HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha |
| Q37266075 | HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas. |
| Q33678960 | HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells. |
| Q34556390 | HIV-1 Tat vaccines |
| Q46346144 | HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently |
| Q36656715 | HIV-1 immunopathogenesis: how good interferon turns bad. |
| Q46458296 | High plasma activity of endogenous antioxidants protect CD4+ T-cells in HIV-serodiscordant heterosexual partners in a Nigerian population |
| Q35576894 | Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection |
| Q36926499 | Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women |
| Q36203752 | Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? |
| Q34234127 | Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors |
| Q34792498 | Human retroviruses after 20 years: a perspective from the past and prospects for their future control |
| Q41829648 | IFN-α inhibits telomerase in human CD8⁺ T cells by both hTERT downregulation and induction of p38 MAPK signaling |
| Q35208314 | IL-7 receptor recovery on CD8 T-cells isolated from HIV+ patients is inhibited by the HIV Tat protein |
| Q31887780 | Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein. |
| Q37592654 | Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein |
| Q53888368 | Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes. |
| Q40931458 | Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein |
| Q33908773 | Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis |
| Q40739621 | Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense |
| Q55153874 | Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure. |
| Q33983425 | Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells |
| Q73486184 | Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection |
| Q34781801 | Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression |
| Q37773243 | Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer |
| Q51998598 | Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys. |
| Q22242658 | Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS |
| Q37295610 | Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes. |
| Q35020357 | Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. |
| Q28246872 | Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection |
| Q61641127 | NOVEL STRATEGIES TOWARD THE DEVELOPMENT OF AN EFFECTIVE VACCINE TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ACQUIRED IMMUNODEFICIENCY VIRUS* |
| Q42929418 | Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. |
| Q33793151 | Novel biologic approaches for the treatment of AIDS. |
| Q39683362 | Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein |
| Q24555821 | Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta |
| Q24684750 | Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication |
| Q33608661 | Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients |
| Q43581520 | Plasmid DNA encoding caprine interferon gamma inhibits antibody response to caprine arthritis-encephalitis virus (CAEV) surface protein encoded by a co-administered plasmid expressing CAEV env and tat genes |
| Q39699309 | Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine |
| Q24799564 | Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes |
| Q34014711 | Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells |
| Q34263935 | Repression of MHC determinants in HIV infection |
| Q33886159 | Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response |
| Q73056614 | Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta |
| Q40273841 | Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein |
| Q36416882 | SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice |
| Q28214887 | Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication |
| Q35993736 | Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine |
| Q37150920 | Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes |
| Q34755910 | Tat-neutralizing antibodies in vaccinated macaques |
| Q45231619 | Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides |
| Q35040673 | The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses |
| Q34460375 | The basis for HIV immunotherapeutic vaccines |
| Q43818994 | The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years |
| Q33971042 | The function of type I interferons in antimicrobial immunity. |
| Q79274214 | Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation |
| Q37825906 | Tits and bits of HIV Tat protein. |
| Q39654386 | Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis |
| Q35155025 | Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir |
| Q107273163 | Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation |
| Q36889683 | Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion |
| Q34173884 | Using death to one's advantage: HIV modulation of apoptosis |
| Q35114827 | Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques |
Search more.